CSL Behring at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
CSL Behring brings 3 presentations to ASH 2026 in New Orleans. Its research spans real-world outcomes in blood and iron disorders and the biology of sickle cell disease. It covers hereditary hemochromatosis, infection treatment in myeloma, and blocking a receptor to calm neutrophils in sickle cell disease.
| Organization | ASH 2026 Attendance |
|---|---|
CSL Behring King of Prussia, PA | |
Biopharmaceutical company developing and supplying therapies for bleeding disorders and other conditions. | Exhibitor meeting room at the convention center, no exhibit-hall booth Oral Sat Dec 12 2:00pm–3:30pm Poster Sun Dec 13 6:00pm–8:00pm |
Find decision makers at CSL Behring
Tell us what you sell and we’ll find the people at CSL Behring most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction